TG
Thamilvanan Gunalan
About Thamilvanan Gunalan
Data last updated:
Thamilvanan Gunalan is a Director at Medwell Women's Speciality Clinic Private Limited (since 2022) and Director at Q Genix Pharma Labs Private Limited (since 2024). The companies operate in Healthcare. The largest current company by reported revenue is Medwell Women's Speciality Clinic Private Limited at ₹14.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Medwell Women's Speciality Clinic Private Limited U85190TN2022PTC149309 | Director | 20 Jan 2022 | 2022 | ₹14.5 Lakh (FY 2025) | Active |
| Q Genix Pharma Labs Private Limited U47721TN2024PTC170942 | Director | 11 Jun 2024 | 2024 | Active |
Board colleagues of Thamilvanan Gunalan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Velupillai Anusuya | 08103539 | Medwell Women's Speciality Clinic Private Limited | Director |
| Balasubramanian Muhaveni | 10663541 | Q Genix Pharma Labs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Thamilvanan Gunalan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Thamilvanan Gunalan
Thamilvanan Gunalan currently holds 2 directorships: Medwell Women's Speciality Clinic Private Limited (Director, since 20 Jan 2022, revenue ₹14.5 Lakh (FY 2025)); Q Genix Pharma Labs Private Limited (Director, since 11 Jun 2024).
Thamilvanan Gunalan was first appointed on 20 Jan 2022 as Director at Medwell Women's Speciality Clinic Private Limited. The most recent appointment on record is 11 Jun 2024 at Q Genix Pharma Labs Private Limited.
The current boards of Thamilvanan Gunalan's companies include Velupillai Anusuya (Medwell Women's Speciality Clinic Private Limited), Balasubramanian Muhaveni (Q Genix Pharma Labs Private Limited).